About FDA
Number of highest risk products domestic inspections completed in a month
Cumulative FY 2010 Performance Goal Target: 10,206
Dictionary: A high risk firm is a firm that is producing a food product that may present a high potential for harm if consumed when the food has been prepared under inadequate conditions such as improper processing, storage, handing and distribution.. From this high-risk list, ORA creates a workplan of high-risk inspections to complete for the year.
Fiscal Year - 2010
Cumulative FY 2010 Performance Goal Target: 10,206
| Time | Monthly Guideline to Reach Cumulative FY 2010 Performance Goal Target | Number |
|---|---|---|
| Oct 2009 | 679 | 683 |
| Nov 2009 | 679 | 898 |
| Dec 2009 | 679 | 916 |
| Jan 2010 | 1,022 | 888 |
| Feb 2010 | 1,022 | 873 |
| Mar 2010 | 1,022 | 1,175 |
| Apr 2010 | 1,022 | 927 |
| May 2010 | 1,022 | 966 |
| Jun 2010 | 1,022 | 1,368 |
| Jul 2010 | 679 | 850 |
| Aug 2010 | 680 | 947 |
| Sep 2010 | 680 | 896 |
FY 2010 YTD: 11,401
Cumulative annual highest risk product domestic inspections completed by the end of the month
Cumulative FY 2010 Performance Goal Target: 10,208
Fiscal Year - 2010
Cumulative FY 2010 Performance Goal Target: 10,208
| Time | Target | Number |
|---|---|---|
| Oct 2009 | N/A | 683 |
| Nov 2009 | N/A | 1,581 |
| Dec 2009 | N/A | 2,497 |
| Jan 2010 | N/A | 3,385 |
| Feb 2010 | N/A | 4,258 |
| Mar 2010 | N/A | 5,433 |
| Apr 2010 | N/A | 6,360 |
| May 2010 | N/A | 7,326 |
| Jun 2010 | N/A | 8,694 |
| Jul 2010 | N/A | 9,544 |
| Aug 2010 | N/A | 10,491 |
| Sep 2010 | N/A | 11,387 |
Cumulative percent of annual highest risk product domestic inspections completed at the end of the month
Fiscal Year - 2010
| Time | Target | Cumulative Percent |
|---|---|---|
| Oct 2009 | N/A | 7 |
| Nov 2009 | N/A | 15 |
| Dec 2009 | N/A | 24 |
| Jan 2010 | N/A | 33 |
| Feb 2010 | N/A | 42 |
| Mar 2010 | N/A | 53 |
| Apr 2010 | N/A | 62 |
| May 2010 | N/A | 72 |
| Jun 2010 | N/A | 85 |
| Jul 2010 | N/A | 94 |
| Aug 2010 | N/A | 103 |
| Sep 2010 | N/A | 112 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
